Clinical trial
Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Colon Cancer…
NCT00047164 · National Institutes of Health Clinical Center (CC), NIH · Completed
Key facts
| NCT number | NCT00047164 |
|---|---|
| Title | Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Colon Cancer That Has Not Responded to Vaccine Therapy |
| Official title | A Pilot Study of Ipilimumab (MDX-CTLA4, MDX-010) in Lymphoma |
| Lead sponsor | National Institutes of Health Clinical Center (CC), NIH |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Biological |
| Interventions | ipilimumab |
| Enrollment | 89 |
| Start date | Sep 1, 2002 |
| Primary completion | Sep 1, 2010 |
| Completion | Nov 1, 2010 |
| First posted | Jan 27, 2003 |
| Last update posted | Sep 26, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: